Pharmacogenomic Evaluation in Lung Diseases | Research & Development | Dofollow Social Bookmarking Sites 2016
Facing issue in account approval? email us at info@ipt.pw

Click to Ckeck Our - FREE SEO TOOLS

1
More than one billion people are impacted by chronic and acute lung diseases globally Infact, non-communicable diseases, such as chronic respiratory diseases are among the biggest reasons for fatality (WHO). Despite the growing health and wellness centricity across countries, respiratory conditions have not received the attention they need. If at all they do then it’s more for infectious conditions like Tuberculosis. But when wellness is looked at holistically, healthy lungs and lung health is paramount for overall health and wellbeing. According to WHO, respiratory illnesses lead to over 10per cent disability adjusted life years (DALYs), are second only to cardiovascular conditions such as Stroke in terms of fatality and constitute to 5 of the 30 leading causes of death (WHO ).

Comments

Who Upvoted this Story